Literature DB >> 30589831

Global Patterns and Trends in Pancreatic Cancer Incidence: Age, Period, and Birth Cohort Analysis.

Ganfeng Luo, Yanting Zhang1, Pi Guo2, Huanlin Ji2, Yuejiao Xiao2, Ke Li2.   

Abstract

OBJECTIVES: We aim to provide a global geographical picture of pancreatic cancer incidence and temporal trends from 1973 to 2015 for 41 countries.
METHODS: Joinpoint regression and age-period-cohort model was used.
RESULTS: In 2012, the highest age-adjusted rate was in Central and Eastern Europe for males and North America for females. Most regions showed sex disparities. During the recent 10 years, increasing trends were observed in North America, Western Europe, and Oceania. The greatest increase occurred in France. For recent birth cohorts, cohort-specific increases in risk were pronounced in Australia, Austria, Brazil, Canada, Costa Rica, Denmark, Estonia, France, Israel, Latvia, Norway, Philippines, Republic of Korea, Singapore, Spain, Sweden, the Netherlands, United States, and US white male populations and in Australia, Austria, Brazil, Bulgaria, Canada, China, Czech Republic, Finland, France, Italy, Japan, Lithuania, Norway, Republic of Korea, Singapore, Spain, The Netherlands, United Kingdom, United States, and US white female populations.
CONCLUSIONS: In contrast to the favorable effect of the decrease in smoking prevalence, other factors, including the increased prevalence of obesity and diabetes and increased physical inactivity, increased intake of red or processed meat and inadequate intake of fruits and vegetables are likely to have an unfavorable role in pancreatic cancer incidence worldwide.

Entities:  

Mesh:

Year:  2019        PMID: 30589831     DOI: 10.1097/MPA.0000000000001230

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  18 in total

Review 1.  Transportome Malfunctions and the Hallmarks of Pancreatic Cancer.

Authors:  Qi Ling; Holger Kalthoff
Journal:  Rev Physiol Biochem Pharmacol       Date:  2021       Impact factor: 5.545

2.  Gallstones and risk of cancers of the liver, biliary tract and pancreas: a prospective study within two U.S. cohorts.

Authors:  Xiao Luo; Wanshui Yang; Amit D Joshi; Kana Wu; Tracey G Simon; Chen Yuan; Lina Jin; Lu Long; Mi Na Kim; Chun-Han Lo; Xing Liu; Thomas A Abrams; Brian M Wolpin; Andrew T Chan; Edward L Giovannucci; Xuehong Zhang
Journal:  Br J Cancer       Date:  2022-06-17       Impact factor: 9.075

3.  Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.

Authors:  Rachael Stolzenberg-Solomon; Andriy Derkach; Steven Moore; Stephanie J Weinstein; Demetrius Albanes; Joshua Sampson
Journal:  Gut       Date:  2020-02-14       Impact factor: 23.059

4.  Updated Trends in Cancer in Japan: Incidence in 1985-2015 and Mortality in 1958-2018-A Sign of Decrease in Cancer Incidence.

Authors:  Kota Katanoda; Megumi Hori; Eiko Saito; Akiko Shibata; Yuri Ito; Tetsuji Minami; Sayaka Ikeda; Tatsuya Suzuki; Tomohiro Matsuda
Journal:  J Epidemiol       Date:  2021-02-06       Impact factor: 3.211

5.  Smoking Modifies Pancreatic Cancer Risk Loci on 2q21.3.

Authors:  Evelina Mocci; Prosenjit Kundu; Nilanjan Chatterjee; Alison P Klein; Rachael Stolzenberg-Solomon; William Wheeler; Alan A Arslan; Laura E Beane-Freeman; Paige M Bracci; Paul Brennan; Federico Canzian; Mengmeng Du; Steven Gallinger; Graham G Giles; Phyllis J Goodman; Charles Kooperberg; Loic Le Marchand; Rachel E Neale; Xiao-Ou Shu; Kala Visvanathan; Emily White; Wei Zheng; Demetrius Albanes; Gabriella Andreotti; Ana Babic; William R Bamlet; Sonja I Berndt; Amanda L Blackford; Bas Bueno-de-Mesquita; Julie E Buring; Daniele Campa; Stephen J Chanock; Erica J Childs; Eric J Duell; Charles S Fuchs; J Michael Gaziano; Edward L Giovannucci; Michael G Goggins; Patricia Hartge; Manal M Hassan; Elizabeth A Holly; Robert N Hoover; Rayjean J Hung; Robert C Kurtz; I-Min Lee; Núria Malats; Roger L Milne; Kimmie Ng; Ann L Oberg; Salvatore Panico; Ulrike Peters; Miquel Porta; Kari G Rabe; Elio Riboli; Nathaniel Rothman; Ghislaine Scelo; Howard D Sesso; Debra T Silverman; Victoria L Stevens; Oliver Strobel; Ian M Thompson; Anne Tjonneland; Antonia Trichopoulou; Stephen K Van Den Eeden; Jean Wactawski-Wende; Nicolas Wentzensen; Lynne R Wilkens; Herbert Yu; Fangcheng Yuan; Anne Zeleniuch-Jacquotte; Laufey T Amundadottir; Donghui Li; Eric J Jacobs; Gloria M Petersen; Brian M Wolpin; Harvey A Risch; Peter Kraft
Journal:  Cancer Res       Date:  2021-02-11       Impact factor: 13.312

6.  Trends in the Incidence of Pancreatic Adenocarcinoma in All 50 United States Examined Through an Age-Period-Cohort Analysis.

Authors:  Wilson L da Costa; Abiodun O Oluyomi; Aaron P Thrift
Journal:  JNCI Cancer Spectr       Date:  2020-05-09

7.  Three novel genetic variants in NRF2 signaling pathway genes are associated with pancreatic cancer risk.

Authors:  Wenjun Yang; Hongliang Liu; Bensong Duan; Xinyuan Xu; Dennis Carmody; Sheng Luo; Kyle M Walsh; James L Abbruzzese; Xuefeng Zhang; Xiaoxin Chen; Qingyi Wei
Journal:  Cancer Sci       Date:  2019-05-06       Impact factor: 6.716

8.  Emerging cancer incidence, mortality, hospitalisation and associated burden among Australian cancer patients, 1982 - 2014: an incidence-based approach in terms of trends, determinants and inequality.

Authors:  Rashidul Alam Mahumud; Khorshed Alam; Jeff Dunn; Jeff Gow
Journal:  BMJ Open       Date:  2019-12-15       Impact factor: 2.692

Review 9.  Identification of a competing endogenous RNA network associated with prognosis of pancreatic adenocarcinoma.

Authors:  Wanqing Weng; Zhongjing Zhang; Weiguo Huang; Xiangxiang Xu; Boda Wu; Tingbo Ye; Yunfeng Shan; Keqing Shi; Zhuo Lin
Journal:  Cancer Cell Int       Date:  2020-06-11       Impact factor: 5.722

10.  Serum Immunoglobulin G Is Associated With Decreased Risk of Pancreatic Cancer in the Swedish AMORIS Study.

Authors:  Sam Sollie; Aida Santaolalla; Dominique S Michaud; Debashis Sarker; Sophia N Karagiannis; Debra H Josephs; Niklas Hammar; Goran Walldius; Hans Garmo; Lars Holmberg; Ingmar Jungner; Mieke Van Hemelrijck
Journal:  Front Oncol       Date:  2020-02-28       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.